Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Double-Blinded Randomized Placebo-controlled Multicenter Study Evaluating the Impact of Dietary Supplement "Tertinat" on Major Adverse Cardiovascular Events in ATherosclerotic Patients After Coronary Revascularization Surgery.

NCT06590012 is registered in ClinicalTrials.gov with Institute for Atherosclerosis Research, Russia as lead sponsor.

NCT NCT06590012
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06590012 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Double-Blinded Randomized Placebo-controlled Multicenter Study Evaluating the Impact of Dietary Supplement "Tertinat" on Major Adverse Cardiovascular Events in ATherosclerotic Patients After Coronary Revascularization Surgery.
Lead sponsor
Institute for Atherosclerosis Research, Russia
Phase
Phase 2
Overall status
Active, not recruiting
Start date
August 29, 2024
Completion date
August 31, 2027
Enrollment
1,228 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

atheroscleroses, coronary, atherosclerosis, carotid atherosclerosis